According to Neogen's latest financial reports the company's current revenue (TTM) is $0.92 B. In 2022 the company made a revenue of $0.63 B an increase over the years 2021 revenue that were of $0.50 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.91 B | 45.66% |
2022 | $0.63 B | 25.4% |
2021 | $0.50 B | 16.08% |
2020 | $0.43 B | 3.98% |
2019 | $0.41 B | 1.41% |
2018 | $0.41 B | 7.53% |
2017 | $0.38 B | 12.01% |
2016 | $0.34 B | 13.16% |
2015 | $0.30 B | 13.64% |
2014 | $0.26 B | 17.81% |
2013 | $0.22 B | 16.13% |
2012 | $0.19 B | 9.92% |
2011 | $0.17 B | 10.42% |
2010 | $0.15 B | 26.47% |
2009 | $0.12 B | 12.5% |
2008 | $0.11 B | 19.65% |
2007 | $93.84 M | 17.59% |
2006 | $79.8 M | 21.95% |
2005 | $65.44 M | 4.94% |
2004 | $62.36 M | 27.02% |
2003 | $49.09 M | 12% |
2002 | $43.83 M | 14.78% |
2001 | $38.19 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $42.85 B | 4,512.06% | ๐บ๐ธ USA |
Becton Dickinson BDX | $19.49 B | 1,997.63% | ๐บ๐ธ USA |
IDEXX Laboratories IDXX | $3.66 B | 293.97% | ๐บ๐ธ USA |
Illumina ILMN | $4.50 B | 384.70% | ๐บ๐ธ USA |
Danaher DHR | $23.89 B | 2,470.92% | ๐บ๐ธ USA |
PerkinElmer
PKI | $3.35 B | 261.31% | ๐บ๐ธ USA |
Pacific Biosciences
PACB | $0.20 B | -78.42% | ๐บ๐ธ USA |
Meridian Bioscience VIVO | $0.33 B | -64.16% | ๐บ๐ธ USA |